Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Süleyman Alıcı (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation
Prof. Dr. Süleyman Alıcı is a distinguished clinical oncologist with over 34 years of experience in internal medicine and medical oncology. He currently practices at Hisar Hospital Intercontinental in Istanbul, Turkey, where he specializes in comprehensive cancer care.
- Full Name: Prof. Dr. Süleyman Alıcı
- Years of Experience: 34 years
- Main Specialty: Clinical Oncology
Educational Background
Prof. Dr. Alıcı has an extensive academic background in medicine and oncology:
- 1990: Graduated from Atatürk University Faculty of Medicine
- 1991–1995: Specialized in Internal Medicine at Selçuk University Faculty of Medicine
- 1997–2000: Subspecialty training in Medical Oncology at Istanbul University Faculty of Medicine (Çapa Medicine)
- 2004: Earned the title of Associate Professor at Yüzüncü Yıl University Faculty of Medicine
Professional Experience
Prof. Dr. Alıcı’s professional journey includes significant roles in various esteemed institutions:
- Current: Clinical Oncologist at Hisar Hospital Intercontinental, Istanbul
- 2005–2008: Chief of Medical Oncology Clinic at Ankara Atatürk Training and Research Hospital
- 2008–2016: Professor at Bahçeşehir University Faculty of Medicine, Medicalpark Göztepe Hospital
- 2017: Joined Acıbadem Healthcare Group
Academic Contributions
Prof. Dr. Alıcı has made significant academic contributions:
- Published over 70 articles in international peer-reviewed journals
- Authored more than 50 scientific studies in domestic journals
- Presented over 100 papers at national and international scientific meetings
- Received more than 10 scientific publication incentive awards from TÜBİTAK and medical oncology associations
Areas of Expertise
Prof. Dr. Alıcı specializes in the diagnosis and treatment of various cancers:
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Ovarian Cancer
- Gastric Cancer
- Prostate Cancer
- Melanomas
He is proficient in cancer therapy, immunotherapy, and personalized treatment plans tailored to individual patient needs.
Publications and Research
Prof. Dr. Alıcı’s research interests are reflected in his numerous publications:
- Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer – Investigates biomarkers for breast cancer prognosis.
- Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma – Evaluates factors influencing survival in gastric cancer patients.
- Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer – Studies survival outcomes in early-stage lung cancer patients.
His research profiles can be found on platforms such as ResearchGate and Google Scholar.
Patient Care Philosophy
Prof. Dr. Alıcı is committed to providing compassionate and patient-centered care:
- Emphasizes clear communication and patient education
- Develops individualized treatment plans based on the latest scientific evidence
- Offers online pre-consultations for international patients
- Focuses on cultural sensitivity and patient satisfaction
Professional Affiliations
Prof. Dr. Alıcı is an active member of several professional organizations:
- European Society of Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Various national oncology associations in Turkey
FAQs
- Is Dr. Süleyman Alıcı board-certified?
- Yes, he holds board certifications in Internal Medicine and Medical Oncology in Turkey.
- What types of treatments does he provide?
- He specializes in chemotherapy, immunotherapy, and targeted therapy for various cancers, including breast, lung, colon, and gastric cancers.
- Does he treat international patients?
- Yes, Dr. Alıcı offers consultations and treatment plans for international patients, including online pre-consultations.
- How long is the typical hospital stay for cancer treatment?
- The duration varies depending on the treatment plan; outpatient chemotherapy sessions may not require hospitalization, while more intensive treatments might necessitate longer stays.
- What languages does he speak?
- Dr. Alıcı is fluent in Turkish and English, facilitating communication with a broad range of patients.